Sangamo Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of SGMO for the last quarter is 481.00 k USD, and it's 76.44% lower compared to the previous quarter. The net income of Q1 24 is -49.09 M USD.